194 related articles for article (PubMed ID: 14647246)
41. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
[TBL] [Abstract][Full Text] [Related]
42. [Infections in solid organ transplant recipients].
Cuellar-Rodríguez J; Sierra-Madero JG
Rev Invest Clin; 2005; 57(2):368-80. PubMed ID: 16524080
[TBL] [Abstract][Full Text] [Related]
43. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
44. [Early bacterial infections in 103 patients treated with bone marrow transplantation].
Tomás JF; Hernández LM; Peñarrubia MJ; Figuera A; Jiménez ML; Cámara R; Arranz R; López JL; Cruz J; Fernández-Rañada JM
Sangre (Barc); 1994 Jun; 39(3):191-6. PubMed ID: 7940049
[TBL] [Abstract][Full Text] [Related]
45. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation.
Dettenkofer M; Ebner W; Bertz H; Babikir R; Finke J; Frank U; Rüden H; Daschner FD
Bone Marrow Transplant; 2003 May; 31(9):795-801. PubMed ID: 12732887
[TBL] [Abstract][Full Text] [Related]
46. Strategies to prevent or control infections after bone marrow transplants.
Karp JE; Merz WG; Dick JD; Saral R
Bone Marrow Transplant; 1991 Jul; 8(1):1-6. PubMed ID: 1912952
[TBL] [Abstract][Full Text] [Related]
47. Aspergillus infections in bone marrow transplant recipients.
Wingard JR; Beals SU; Santos GW; Merz WG; Saral R
Bone Marrow Transplant; 1987 Aug; 2(2):175-81. PubMed ID: 3332165
[TBL] [Abstract][Full Text] [Related]
48. Systemic lupus erythematosus and infections: a retrospective study in Saudis.
Al-Rayes H; Al-Swailem R; Arfin M; Sobki S; Rizvi S; Tariq M
Lupus; 2007; 16(9):755-63. PubMed ID: 17728372
[TBL] [Abstract][Full Text] [Related]
49. Infectious diseases in the liver transplant recipient.
Singh N
Semin Gastrointest Dis; 1998 Jul; 9(3):136-46. PubMed ID: 9700844
[TBL] [Abstract][Full Text] [Related]
50. A pilot study on the role of cytomegalovirus & human herpesvirus-6 infections in Indian bone marrow transplant recipients.
Finny GJ; Mathews V; Abraham P; Abraham M; Chandy M; Srivastava A; Nitsche A; Siegert W; Sridharan G
Indian J Med Res; 2001 Aug; 114():39-46. PubMed ID: 11785448
[TBL] [Abstract][Full Text] [Related]
51. Infections in bone marrow transplant recipients in south India--a post-mortem study.
Ramani P; Krishnaswami H; Srivastava A; Dennison D; Chandy M
J Trop Med Hyg; 1994 Dec; 97(6):354-6. PubMed ID: 7966537
[TBL] [Abstract][Full Text] [Related]
52. Bone marrow transplantation: the City of Hope experience.
Smith EP; Nademanee A
Clin Transpl; 1995; ():291-310. PubMed ID: 8794275
[TBL] [Abstract][Full Text] [Related]
53. Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis.
Klastersky J
Clin Ther; 1985; 8(1):90-9. PubMed ID: 3914372
[TBL] [Abstract][Full Text] [Related]
54. Virus infections complicating bone marrow transplantation.
Rogers TR
Clin Ter; 1992 Feb; 140(2):131-6. PubMed ID: 1314724
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients.
De La Rosa GR; Champlin RE; Kontoyiannis DP
Transpl Infect Dis; 2002 Mar; 4(1):3-9. PubMed ID: 12123420
[TBL] [Abstract][Full Text] [Related]
56. Etiology of diarrhea in patients undergoing allogeneic bone marrow transplantation in South India.
Kang G; Srivastava A; Pulimood AB; Dennison D; Chandy M
Transplantation; 2002 Apr; 73(8):1247-51. PubMed ID: 11981416
[TBL] [Abstract][Full Text] [Related]
57. Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients.
Tollemar J; Gross N; Dolgiras N; Jarstrand C; Ringdén O; Hammarström L
Bone Marrow Transplant; 1999 Feb; 23(3):283-90. PubMed ID: 10084261
[TBL] [Abstract][Full Text] [Related]
58. Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation: a study of 176 transplants.
García S; Roque J; Ruza F; González M; Madero R; Alvarado F; Herruzo R
Clin Transplant; 1998 Jun; 12(3):190-7. PubMed ID: 9642509
[TBL] [Abstract][Full Text] [Related]
59. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens.
Singh N; Wagener MM; Obman A; Cacciarelli TV; de Vera ME; Gayowski T
Liver Transpl; 2004 Jul; 10(7):844-9. PubMed ID: 15237367
[TBL] [Abstract][Full Text] [Related]
60. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
